$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

[해외논문] What we know and what we need to know about adenovirus 36-induced obesity

International journal of obesity : journal of the International Association for the Study of Obesity, v.44 no.6, 2020년, pp.1197 - 1209  

Kim, Jihye ,  Na, Hana ,  Kim, Jung-Ae ,  Nam, Jae-Hwan

초록이 없습니다.

참고문헌 (120)

  1. Science. MJ Lyons 216 82 1982 10.1126/science.7038878 Lyons MJ, Faust IM, Hemmes RB, Buskirk DR, Hirsch J, Zabriskie JB. A virally induced obesity syndrome in mice. Science. 1982;216:82-5. 

  2. Vet Microbiol. NV Dhurandhar 31 101 1992 10.1016/0378-1135(92)90068-5 Dhurandhar NV, Kulkarni P, Ajinkya SM, Sherikar A. Effect of adenovirus infection on adiposity in chicken. Vet Microbiol. 1992;31:101-7. 

  3. Am J Physiol Regul Integr Comp Physiol LD Whigham 290 R190 2006 10.1152/ajpregu.00479.2005 Whigham LD, Israel BA, Atkinson RL. Adipogenic potential of multiple human adenoviruses in vivo and in vitro in animals. Am J Physiol Regul Integr Comp Physiol. 2006;290:R190-4. 

  4. Obes Rev. M Akheruzzaman 20 499 2019 10.1111/obr.12808 Akheruzzaman M, Hegde V, Dhurandhar NV. Twenty-five years of research about adipogenic adenoviruses: a systematic review. Obes Rev. 2019;20:499-509. 

  5. Int J Obes (Lond) NV Dhurandhar 25 990 2001 10.1038/sj.ijo.0801668 Dhurandhar NV, Israel BA, Kolesar JM, Mayhew G, Cook ME, Atkinson RL. Transmissibility of adenovirus-induced adiposity in a chicken model. Int J Obes (Lond). 2001;25:990-6. 

  6. Arch Virol. DA Montes-Galindo 164 775 2019 10.1007/s00705-018-04132-6 Montes-Galindo DA, Espiritu-Mojarro AC, Melnikov V, Moy-López NA, Soriano-Hernandez AD, Galvan-Salazar HR, et al. Adenovirus 5 produces obesity and adverse metabolic, morphological, and functional changes in the long term in animals fed a balanced diet or a high-fat diet: a study on hamsters. Arch Virol. 2019;164:775-86. 

  7. J Nutr NV Dhurandhar 132 3155 2002 10.1093/jn/131.10.3155 Dhurandhar NV, Whigham LD, Abbott DH, Schultz-Darken NJ, Israel BA, Bradley SM, et al. Human adenovirus Ad-36 promotes weight gain in male rhesus and marmoset monkeys. J Nutr. 2002;132:3155-60. 

  8. Arch Virol. M Pasarica 153 2097 2008 10.1007/s00705-008-0219-2 Pasarica M, Loiler S, Dhurandhar NV. Acute effect of infection by adipogenic human adenovirus Ad36. Arch Virol. 2008;153:2097-102. 

  9. PLoS One. HN Na 9 2014 10.1371/journal.pone.0114534 Na HN, Hong YM, Michael BY, Park SH, Kim IB, Nam JH. Adenovirus 36 attenuates weight loss from exercise but improves glycemic control by increasing mitochondrial activity in the liver. PLoS One. 2014;9:e114534. 

  10. Obesity (Silver Spring) Q Shang 22 895 2014 10.1002/oby.20533 Shang Q, Wang H, Song Y, Wei L, Lavebratt C, Zhang F, et al. Serological data analyses show that adenovirus 36 infection is associated with obesity: a meta-analysis involving 5739 subjects. Obesity (Silver Spring). 2014;22:895-900. 

  11. Medicine. MY Xu 94 2015 10.1097/MD.0000000000002357 Xu MY, Cao B, Wang DF, Guo JH, Chen KL, Shi M, et al. Human adenovirus 36 infection increased the risk of obesity: a meta-analysis update. Medicine. 2015;94:e2357. 

  12. PLoS One. T Yamada 7 2012 10.1371/journal.pone.0042031 Yamada T, Hara K, Kadowaki T. Association of adenovirus 36 infection with obesity and metabolic markers in humans: a meta-analysis of observational studies. PLoS One. 2012;7:e42031. 

  13. Int J Obes (Lond) RL Atkinson 29 281 2005 10.1038/sj.ijo.0802830 Atkinson RL, Dhurandhar NV, Allison DB, Bowen RL, Israel BA, Albu JB, et al. Human adenovirus-36 is associated with increased body weight and paradoxical reduction of serum lipids. Int J Obes (Lond). 2005;29:281-6. 

  14. Int J Pediatr Obes RL Atkinson 5 157 2010 10.3109/17477160903111789 Atkinson RL, Lee I, Shin HJ, He J. Human adenovirus-36 antibody status is associated with obesity in children. Int J Pediatr Obes. 2010;5:157-60. 

  15. Int J Obes (Lond) M Broderick 34 302 2010 10.1038/ijo.2009.224 Broderick M, Hansen C, Irvine M, Metzgar D, Campbell K, Baker C, et al. Adenovirus 36 seropositivity is strongly associated with race and gender, but not obesity, among US military personnel. Int J Obes (Lond). 2010;34:302-8. 

  16. Pediatrics. C Gabbert 126 721 2010 10.1542/peds.2009-3362 Gabbert C, Donohue M, Arnold J, Schwimmer JB. Adenovirus 36 and obesity in children and adolescents. Pediatrics. 2010;126:721-6. 

  17. Obesity. VJ Goossens 19 220 2011 10.1038/oby.2009.452 Goossens VJ, de Jager SA, Grauls GE, Gielen M, Vlietinck RF, Derom CA, et al. Lack of evidence for the role of human adenovirus‐36 in obesity in a European cohort. Obesity. 2011;19:220-1. 

  18. Int J Obes (Lond) HN Na 34 89 2010 10.1038/ijo.2009.207 Na HN, Hong YM, Kim J, Kim HK, Jo I, Nam JH. Association between human adenovirus-36 and lipid disorders in Korean schoolchildren. Int J Obes (Lond). 2010;34:89-93. 

  19. Int J Obes (Lond) HN Na 36 281 2012 10.1038/ijo.2011.102 Na HN, Kim J, Lee HS, Shim KW, Kimm H, Jee SH, et al. Association of human adenovirus-36 in overweight Korean adults. Int J Obes (Lond). 2012;36:281-5. 

  20. Int J Obes (Lond) GM Trovato 33 1402 2009 10.1038/ijo.2009.196 Trovato GM, Castro A, Tonzuso A, Garozzo A, Martines GF, Pirri C, et al. Human obesity relationship with Ad36 adenovirus and insulin resistance. Int J Obes (Lond). 2009;33:1402-9. 

  21. Liver Int GM Trovato 30 184 2010 10.1111/j.1478-3231.2009.02127.x Trovato GM, Martines GF, Garozzo A, Tonzuso A, Timpanaro R, Pirri C, et al. Ad36 adipogenic adenovirus in human non‐alcoholic fatty liver disease. Liver Int. 2010;30:184-90. 

  22. Dig Dis Sci GM Trovato 57 535 2012 10.1007/s10620-011-1903-8 Trovato GM, Martines GF, Trovato FM, Pirri C, Pace P, Garozzo A, et al. Adenovirus-36 seropositivity enhances effects of nutritional intervention on obesity, bright liver, and insulin resistance. Dig Dis Sci. 2012;57:535-44. 

  23. PLoS One. M Almgren 7 2012 10.1371/journal.pone.0041652 Almgren M, Atkinson R, He J, Hilding A, Hagman E, Wolk A, et al. Adenovirus-36 is associated with obesity in children and adults in Sweden as determined by rapid ELISA. PLoS One. 2012;7:e41652. 

  24. Diabetes Care. WY Lin 36 701 2013 10.2337/dc12-1089 Lin WY, Dubuisson O, Rubicz R, Liu N, Allison DB, Curran JE, et al. Long-term changes in adiposity and glycemic control are associated with past adenovirus infection. Diabetes Care. 2013;36:701-7. 

  25. Mo Med. AK Tosh 109 402 2012 Tosh AK, Bray-Aschenbrenner A, El Khatib J, Ge B. Adenovirus-36 antibody status & BMI comparison among obese Missouri adolescents. Mo Med. 2012;109:402-3. 

  26. J Clin Endocrinol Metab PK Berger 99 3240 2014 10.1210/jc.2014-1780 Berger PK, Pollock NK, Laing EM, Warden SJ, Hill Gallant K, Hausman DB, et al. Association of adenovirus 36 infection with adiposity and inflammatory-related markers in children. J Clin Endocrinol Metab. 2014;99:3240-6. 

  27. Epidemiol Infect. M Karamese 143 3550 2015 10.1017/S0950268815000679 Karamese M, Altoparlak U, Turgut A, Aydogdu S, Karamese SA. The relationship between adenovirus-36 seropositivity, obesity and metabolic profile in Turkish children and adults. Epidemiol Infect. 2015;143:3550-6. 

  28. J Bone Miner Res EM Laing 28 489 2013 10.1002/jbmr.1776 Laing EM, Tripp RA, Pollock NK, Baile CA, Della‐Fera MA, Rayalam S, et al. Adenovirus 36, adiposity, and bone strength in late‐adolescent females. J Bone Miner Res. 2013;28:489-96. 

  29. Int J Endocrinol I Parra-Rojas 2013 2013 10.1155/2013/463194 Parra-Rojas I, Moral-Hernández D, Salgado-Bernabé AB, Guzmán-Guzmán IP, Salgado-Goytia L, Muñoz-Valle JF. Adenovirus-36 seropositivity and its relation with obesity and metabolic profile in children. Int J Endocrinol. 2013;2013:e463194. 

  30. Int J Obes (Lond) M Sabin 39 1644 2015 10.1038/ijo.2015.108 Sabin M, Burgner D, Atkinson R, Lee ZP-L, Magnussen C, Cheung M, et al. Longitudinal investigation of adenovirus 36 seropositivity and human obesity: the Cardiovascular Risk in Young Finns Study. Int J Obes (Lond). 2015;39:1644-50. 

  31. Obes Facts. JS Vander Wal 6 269 2013 10.1159/000353109 Vander Wal JS, Huelsing J, Dubuisson O, Dhurandhar NV. An observational study of the association between adenovirus 36 antibody status and weight loss among youth. Obes Facts. 2013;6:269-78. 

  32. J Investig Med EK Cakmakliogullari 62 821 2014 10.2310/JIM.0000000000000084 Cakmakliogullari EK, Sanlidag T, Ersoy B, Akcali S, Var A, Cicek C. Are human adenovirus-5 and 36 associated with obesity in children? J Investig Med. 2014;62:821-4. 

  33. J Xi’an Jiaotong Univ X Chang 36 219 2015 Chang X, Yi J, Jian-Fei L, Ya-qun G. The regulation of adenovirus type 36 infection and progranulin expression in Uygur obese patients. J Xi’an Jiaotong Univ. 2015;36:219. 

  34. Microb Pathog. S Ergin 80 57 2015 10.1016/j.micpath.2015.02.008 Ergin S, Altan E, Pilanci O, Sirekbasan S, Cortuk O, Cizmecigil U, et al. The role of adenovirus 36 as a risk factor in obesity: the first clinical study made in the fatty tissues of adults in Turkey. Microb Pathog. 2015;80:57-62. 

  35. Occup Health I Wang 24 2087 2008 Wang I, Lin L, Li T. Role of adenovirus infection and obese gene mutation in obestiy. Occup Health. 2008;24:2087-9. 

  36. Int J Obes (Lond) I Aldhoon-Hainerová 38 285 2014 10.1038/ijo.2013.72 Aldhoon-Hainerová I, Zamrazilová H, Atkinson RL, Dušátková L, Sedláčková B, Hlavatý P, et al. Clinical and laboratory characteristics of 1179 Czech adolescents evaluated for antibodies to human adenovirus 36. Int J Obes (Lond). 2014;38:285-91. 

  37. J Clin Endocrinol Metab JD Voss 99 E1708 2014 10.1210/jc.2014-1863 Voss JD, Burnett DG, Olsen CH, Haverkos HW, Atkinson RL. Adenovirus 36 antibodies associated with clinical diagnosis of overweight/obesity but not BMI gain: a military cohort study. J Clin Endocrinol Metab. 2014;99:E1708-12. 

  38. International Journal of Obesity Jorge Sapunar 44 1 159 2019 10.1038/s41366-019-0321-4 Sapunar J, Fonseca L, Molina V, Ortiz E, Barra MI, Reimer C et al. Adenovirus 36 seropositivity is related to obesity risk, glycemic control, and leptin levels in Chilean subjects. Int J Obes (Lond). 2019; https://doi.org/10.1038/s41366-019-0321-4. 

  39. Microb Pathog. B Kocazeybek 108 27 2017 10.1016/j.micpath.2017.04.034 Kocazeybek B, Dinc HO, Ergin S, Saribas S, Ozcabi BT, Cizmecigil U, et al. Evaluation of adenovirus-36 (Ad-36) antibody seropositivity and adipokine levels in obese children. Microb Pathog. 2017;108:27-31. 

  40. 10.1515/ijamh-2018-0110 LaVoy EC, Arlinghaus KR, Rooney BV, Gupta P, Atkinson R, Johnston CA. High adenovirus 36 seroprevalence among a population of Hispanic American youth. Int J Adolesc Med Health. 2018; https://doi.org/10.1515/ijamh-2018-0110. 

  41. 10.1515/ijamh-2017-0126 Tosh AK, Wasserman MG, McLeay II MT, Tepe SK. Human adenovirus-36 seropositivity and obesity among Midwestern US adolescents. Int J Adolesc Med Health. 2017; https://doi.org/10.1515/ijamh-2017-0126. 

  42. Hong Kong Med J. MMY Waye 21 45 2015 Waye MMY, Chan JCN, Tong PCY, Ma R, Chan PKS. Association of human adenovirus-36 with diabetes, adiposity, and dyslipidaemia in Hong Kong Chinese. Hong Kong Med J. 2015;21:45-7. 

  43. Biosci Rep. Y Zhou 38 BSR20180553 2018 10.1042/BSR20180553 Zhou Y, Pan Q, Wang X, Zhang L, Xiao F, Guo L. The relationship between human adenovirus 36 and obesity in Chinese Han population. Biosci Rep. 2018;38:BSR20180553. 

  44. Obesity. M Pasarica 14 1905 2006 10.1038/oby.2006.222 Pasarica M, Shin AC, Yu M, Yang HMO, Rathod M, Jen KLC, et al. Human adenovirus 36 induces adiposity, increases insulin sensitivity, and alters hypothalamic monoamines in rats. Obesity. 2006;14:1905-13. 

  45. Acta Virol KA Hwang 62 350 2018 10.4149/av_2018_402 Hwang KA, Park S, Ahn JH, Nam JH. Development of a standard protocol for quantitative polymerase chain reaction to detect adenovirus 36, which is associated with obesity. Acta Virol. 2018;62:350-9. 

  46. Lab Anim. R Krishnapuram 45 103 2011 10.1258/la.2010.010084 Krishnapuram R, Kirk-Ballard H, Zuberi A, Dhurandhar NV. Infectivity period of mice inoculated with human adenoviruses. Lab Anim. 2011;45:103-8. 

  47. Mol Cell Biochem Y Jiao 428 1 2017 10.1007/s11010-016-2912-x Jiao Y, Aisa Y, Liang X, Nuermaimaiti N. Regulation of PPAR c and CIDEC expression by adenovirus 36 in adipocyte differentiation. Mol Cell Biochem. 2017;428:1-8. 

  48. Int J Obes (Lond) M Rathod 31 78 2006 10.1038/sj.ijo.0803358 Rathod M, Vangipuram SD, Krishnan B, Heydari AR, Holland TC, Dhurandhar NV. Viral mRNA expression but not DNA replication is required for lipogenic effect of human adenovirus Ad-36 in preadipocytes. Int J Obes (Lond). 2006;31:78-86. 

  49. Int J Obes (Lond) PM Rogers 32 397 2007 10.1038/sj.ijo.0803748 Rogers PM, Fusinski KA, Rathod MA, Loiler SA, Pasarica M, Shaw MK, et al. Human adenovirus Ad-36 induces adipogenesis via its E4 orf-1 gene. Int J Obes (Lond). 2007;32:397-406. 

  50. Int J Obes (Lond) SD Vangipuram 31 87 2006 10.1038/sj.ijo.0803366 Vangipuram SD, Yu M, Tian J, Stanhope KL, Pasarica M, Havel PJ, et al. Adipogenic human adenovirus-36 reduces leptin expression and secretion and increases glucose uptake by fat cells. Int J Obes (Lond). 2006;31:87-96. 

  51. Int J Obes (Lond) HN Na 36 195 2012 10.1038/ijo.2011.89 Na HN, Kim H, Nam JH. Novel genes and cellular pathways related to infection with adenovirus-36 as an obesity agent in human mesenchymal stem cells. Int J Obes (Lond). 2012;36:195-200. 

  52. Stem Cells. M Pasarica 26 969 2008 10.1634/stemcells.2007-0868 Pasarica M, Mashtalir N, McAllister EJ, Kilroy GE, Koska J, Permana P, et al. Adipogenic human adenovirus Ad‐36 induces commitment, differentiation, and lipid accumulation in human adipose‐derived stem cells. Stem Cells. 2008;26:969-78. 

  53. Obes Res SD Vangipuram 12 770 2004 10.1038/oby.2004.93 Vangipuram SD, Sheele J, Atkinson RL, Holland TC, Dhurandhar NV. A human adenovirus enhances preadipocyte differentiation. Obes Res. 2004;12:770-7. 

  54. Int J Obes (Lond) ZQ Wang 34 1355 2010 10.1038/ijo.2010.77 Wang ZQ, Yu Y, Zhang XH, Floyd EZ, Cefalu WT. Human adenovirus 36 decreases fatty acid oxidation and increases de novo lipogenesis in primary cultured human skeletal muscle cells by promoting Cidec/FSP27 expression. Int J Obes (Lond). 2010;34:1355-64. 

  55. Obesity. MA Rathod 17 657 2009 10.1038/oby.2008.630 Rathod MA, Rogers PM, Vangipuram SD, McAllister EJ, Dhurandhar NV. Adipogenic cascade can be induced without adipogenic media by a human adenovirus. Obesity. 2009;17:657-64. 

  56. Ann Med. M Almgren 46 539 2014 10.3109/07853890.2014.935469 Almgren M, Atkinson RL, Hilding A, He J, Brismar K, Schalling M, et al. Human adenovirus-36 is uncommon in type 2 diabetes and is associated with increased insulin sensitivity in adults in Sweden. Ann Med. 2014;46:539-46. 

  57. J Diabetes. NV Dhurandhar 6 614 2014 10.1111/1753-0407.12178 Dhurandhar NV, Dhurandhar EJ, Ingram DK, Vaughan K, Mattison JA. Natural infection of human adenovirus 36 in rhesus monkeys is associated with a reduction in fasting glucose. J Diabetes. 2014;6:614-6. 

  58. Diabetes. PM Rogers 57 2321 2008 10.2337/db07-1311 Rogers PM, Mashtalir N, Rathod MA, Dubuisson O, Wang Z, Dasuri K, et al. Metabolically favorable remodeling of human adipose tissue by human adenovirus type 36. Diabetes. 2008;57:2321-31. 

  59. Diabetes. ZQ Wang 57 1805 2008 10.2337/db07-1313 Wang ZQ, Cefalu WT, Zhang XH, Yu Y, Qin J, Son L, et al. Human adenovirus type 36 enhances glucose uptake in diabetic and nondiabetic human skeletal muscle cells independent of insulin signaling. Diabetes. 2008;57:1805-13. 

  60. Am J Physiol Endocrinol Metab R Krishnapuram 300 E779 2011 10.1152/ajpendo.00703.2010 Krishnapuram R, Dhurandhar EJ, Dubuisson O, Kirk-Ballard H, Bajpeyi S, Butte N, et al. Template to improve glycemic control without reducing adiposity or dietary fat. Am J Physiol Endocrinol Metab. 2011;300:E779-9. 

  61. Metabolism RME Blümer 57 1655 2008 10.1016/j.metabol.2008.07.020 Blümer RME, van Roomen CP, Meijer AJ, Houben-Weerts JHPM, Sauerwein HP, Dubbelhuis PF. Regulation of adiponectin secretion by insulin and amino acids in 3T3-L1 adipocytes. Metabolism. 2008;57:1655-62. 

  62. Life Sci. RI Pereira 83 638 2008 10.1016/j.lfs.2008.09.002 Pereira RI, Leitner JW, Erickson C, Draznin B. Pioglitazone acutely stimulates adiponectin secretion from mouse and human adipocytes via activation of the phosphatidylinositol 3′-kinase. Life Sci. 2008;83:638-43. 

  63. Nat Med. T Yamauchi 8 1288 2002 10.1038/nm788 Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, Uchida S, et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med. 2002;8:1288-95. 

  64. Genes Dev. M Qatanani 21 1443 2007 10.1101/gad.1550907 Qatanani M, Lazar MA. Mechanisms of obesity-associated insulin resistance: many choices on the menu. Genes Dev. 2007;21:1443-55. 

  65. J Infect Dis HN Na 205 914 2012 10.1093/infdis/jir864 Na HN, Nam JH. Adenovirus 36 as an obesity agent maintains the obesity state by increasing MCP-1 and inducing inflammation. J Infect Dis. 2012;205:914-22. 

  66. Int J Mol Sci L Marseglia 16 378 2014 10.3390/ijms16010378 Marseglia L, Manti S, D’Angelo G, Nicotera A, Parisi E, Di Rosa G, et al. Oxidative stress in obesity: a critical component in human diseases. Int J Mol Sci. 2014;16:378-400. 

  67. Int J Mol Sci D Moseti 17 E124 2016 10.3390/ijms17010124 Moseti D, Regassa A, Kim WK. Molecular regulation of adipogenesis and potential anti-adipogenic bioactive molecules. Int J Mol Sci. 2016;17:E124. 

  68. Genes Dev. ED Rosen 14 1293 2000 10.1101/gad.14.11.1293 Rosen ED, Walkey CJ, Puigserver P, Spiegelman BM. Transcriptional regulation of adipogenesis. Genes Dev. 2000;14:1293-307. 

  69. Clin Med Insights Cardiol M Furuhashi 8 23 2015 Furuhashi M, Saitoh S, Shimamoto K, Miura T. Fatty acid-binding protein 4 (FABP4): pathophysiological insights and potent clinical biomarker of metabolic and cardiovascular diseases. Clin Med Insights Cardiol. 2015;8:23-33. 

  70. Mol Metab. LE Wu 3 465 2014 10.1016/j.molmet.2014.02.005 Wu LE, Samocha-Bonet D, Whitworth PT, Fazakerley DJ, Turner N, Biden TJ, et al. Identification of fatty acid binding protein 4 as an adipokine that regulates insulin secretion during obesity. Mol Metab. 2014;3:465-73. 

  71. Mol Endocrinol. H Xu 30 325 2016 10.1210/me.2015-1301 Xu H, Hertzel AV, Steen KA, Bernlohr DA. Loss of fatty acid binding protein 4/aP2 reduces macrophage inflammation through activation of SIRT3. Mol Endocrinol. 2016;30:325-34. 

  72. Cell. YS Lee 157 1339 2014 10.1016/j.cell.2014.05.012 Lee YS, Kim J-w, Osborne O, Oh DY, Sasik R, Schenk S, et al. Increased adipocyte O2 consumption triggers HIF-1α, causing inflammation and insulin resistance in obesity. Cell. 2014;157:1339-52. 

  73. Physiol Rev. P Trayhurn 93 1 2013 10.1152/physrev.00017.2012 Trayhurn P. Hypoxia and adipose tissue function and dysfunction in obesity. Physiol Rev. 2013;93:1-21. 

  74. Int J Obes (Lond) J Ye 33 54 2009 10.1038/ijo.2008.229 Ye J. Emerging role of adipose tissue hypoxia in obesity and insulin resistance. Int J Obes (Lond). 2009;33:54-66. 

  75. Biochem Biophys Res Commun MK Jang 431 421 2013 10.1016/j.bbrc.2012.12.154 Jang MK, Son YH, Jung MH. ATF3 plays a role in adipocyte hypoxia-mediated mitochondria dysfunction in obesity. Biochem Biophys Res Commun. 2013;431:421-7. 

  76. Diabetes. EH Koh 56 2973 2007 10.2337/db07-0510 Koh EH, Park JY, Park HS, Jeon MJ, Ryu JW, Kim M, et al. Essential role of mitochondrial function in adiponectin synthesis in adipocytes. Diabetes. 2007;56:2973-81. 

  77. Antioxid Redox Signal WI Sivitz 12 537 2010 10.1089/ars.2009.2531 Sivitz WI, Yorek MA. Mitochondrial dysfunction in diabetes: from molecular mechanisms to functional significance and therapeutic opportunities. Antioxid Redox Signal. 2010;12:537-77. 

  78. Proc Natl Acad Sci USA F Bäckhed 101 15718 2004 10.1073/pnas.0407076101 Bäckhed F, Ding H, Wang T, Hooper LV, Koh GY, Nagy A, et al. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci USA. 2004;101:15718-23. 

  79. Int J Endocrinol O Castaner 2018 4095789 2018 Castaner O, Goday A, Park Y-M, Lee S-H, Magkos F, Shiow S-ATE, et al. The gut microbiome profile in obesity: a systematic review. Int J Endocrinol. 2018;2018:4095789. 

  80. Nature. PJ Turnbaugh 444 1027 2006 10.1038/nature05414 Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. 2006;444:1027-31. 

  81. BMC Microbiol. A Koliada 17 120 2017 10.1186/s12866-017-1027-1 Koliada A, Syzenko G, Moseiko V, Budovska L, Puchkov K, Perederiy V, et al. Association between body mass index and Firmicutes/Bacteroidetes ratio in an adult Ukrainian population. BMC Microbiol. 2017;17:120. 

  82. Sci Rep. Wasimuddin 9 2019 10.1038/s41598-019-49829-z Wasimuddin, Corman VM, Ganzhorn JU, Rakotondranary J, Ratovonamana YR, Drosten C, et al. Adenovirus infection is associated with altered gut microbial communities in a non-human primate. Sci Rep. 2019;9:13410. 

  83. International Journal of Obesity Yongming Sang 43 11 2134 2019 10.1038/s41366-019-0323-2 Sang Y, Shields LE, Sang ER, Si H, Pigg A, Blecha F. Ileal transcriptome analysis in obese rats induced by high-fat diets and an adenoviral infection. Int J Obes (Lond). 2019; https://doi.org/10.1038/s41366-019-0323-2. 

  84. Cell. DA Fruman 170 605 2017 10.1016/j.cell.2017.07.029 Fruman DA, Chiu H, Hopkins BD, Bagrodia S, Cantley LC, Abraham RT. The PI3K pathway in human disease. Cell. 2017;170:605-35. 

  85. Diabetes. TB McMurphy 66 358 2017 10.2337/db16-0876 McMurphy TB, Huang W, Xiao R, Liu X, Dhurandhar NV, Cao L. Hepatic expression of adenovirus 36 E4ORF1 improves glycemic control and promotes glucose metabolism through AKT activation. Diabetes. 2017;66:358-71. 

  86. Biochimie. HN Na 124 3 2016 10.1016/j.biochi.2014.11.005 Na HN, Dubuisson O, Hegde V, Nam JH, Dhurandhar NV. Human adenovirus Ad36 and its E4orf1 gene enhance cellular glucose uptake even in the presence of inflammatory cytokines. Biochimie. 2016;124:3-10. 

  87. Oncogene. KK Frese 22 710 2003 10.1038/sj.onc.1206151 Frese KK, Lee SS, Thomas DL, Latorre IJ, Weiss RS, Glaunsinger BA, et al. Selective PDZ protein-dependent stimulation of phosphatidylinositol 3-kinase by the adenovirus E4-ORF1 oncoprotein. Oncogene. 2003;22:710-21. 

  88. PLoS One. EJ Dhurandhar 6 2011 10.1371/journal.pone.0023394 Dhurandhar EJ, Dubuisson O, Mashtalir N, Krishnapuram R, Hegde V, Dhurandhar NV. E4orf1: a novel ligand that improves glucose disposal in cell culture. PLoS One. 2011;6:e23394. 

  89. Int J Obes (Lond) I Yoon 41 1601 2017 10.1038/ijo.2017.142 Yoon I, Park S, Kim R, Ko H, Nam J. Insulin-sparing and fungible effects of E4orf1 combined with an adipocyte-targeting sequence in mouse models of type 1 and type 2 diabetes. Int J Obes (Lond). 2017;41:1601-5. 

  90. Mol Med. L Chang 10 65 2004 10.2119/2005-00029.Saltiel Chang L, Chiang SH, Saltiel AR. Insulin signaling and the regulation of glucose transport. Mol Med. 2004;10:65-71. 

  91. Clin Cancer Res HE Metz 17 206 2011 10.1158/1078-0432.CCR-10-0434 Metz HE, Houghton AM. Insulin receptor substrate regulation of phosphoinositide 3-kinase. Clin Cancer Res. 2011;17:206-11. 

  92. J Clin Invest JE Pessin 106 165 2000 10.1172/JCI10582 Pessin JE, Saltiel AR. Signaling pathways in insulin action: molecular targets of insulin resistance. J Clin Invest. 2000;106:165-9. 

  93. Mol Metab. CM Kusminski 4 653 2015 10.1016/j.molmet.2015.07.004 Kusminski CM, Gallardo-Montejano VI, Wang ZV, Hegde V, Bickel PE, Dhurandhar NV, et al. E4orf1 induction in adipose tissue promotes insulin-independent signaling in the adipocyte. Mol Metab. 2015;4:653-64. 

  94. PLoS One. AA Shastri 13 2018 10.1371/journal.pone.0208427 Shastri AA, Hegde V, Peddibhotla S, Feizy Z, Dhurandhar NV. E4orf1: a protein for enhancing glucose uptake despite impaired proximal insulin signaling. PLoS One. 2018;13:e0208427. 

  95. Int J Obes (Lond) R Krishnapuram 37 146 2013 10.1038/ijo.2012.6 Krishnapuram R, Kirk-Ballard H, Dhurandhar EJ, Dubuisson O, Messier V, Rabasa-Lhoret R, et al. Insulin receptor-independent upregulation of cellular glucose uptake. Int J Obes (Lond). 2013;37:146-53. 

  96. PLoS One. HN Na 11 2016 10.1371/journal.pone.0161275 Na HN, Hegde V, Dubuisson O, Dhurandhar NV. E4orf1 enhances glucose uptake independent of proximal insulin signaling. PLoS One. 2016;11:e0161275. 

  97. Oncogene. G Jinesh 37 839 2018 10.1038/onc.2017.377 Jinesh G, Sambandam V, Vijayaraghavan S, Balaji K, Mukherjee S. Molecular genetics and cellular events of K-Ras-driven tumorigenesis. Oncogene. 2018;37:839-46. 

  98. Genes Dev. MI Lefterova 22 2941 2008 10.1101/gad.1709008 Lefterova MI, Zhang Y, Steger DJ, Schupp M, Schug J, Cristancho A, et al. PPARgamma and C/EBP factors orchestrate adipocyte biology via adjacent binding on a genome-wide scale. Genes Dev. 2008;22:2941-52. 

  99. Nat Med. M Ahmadian 19 557 2013 10.1038/nm.3159 Ahmadian M, Suh JM, Hah N, Liddle C, Atkins AR, Downes M, et al. PPARgamma signaling and metabolism: the good, the bad and the future. Nat Med. 2013;19:557-66. 

  100. J Biol Chem Y Zuo 281 7960 2006 10.1074/jbc.M510682200 Zuo Y, Qiang L, Farmer SR. Activation of CCAAT/enhancer-binding protein (C/EBP) alpha expression by C/EBP beta during adipogenesis requires a peroxisome proliferator-activated receptor-gamma-associated repression of HDAC1 at the C/ebp alpha gene promoter. J Biol Chem. 2006;281:7960-7. 

  101. Mol Cell Biol MS Madsen 34 939 2014 10.1128/MCB.01344-13 Madsen MS, Siersbaek R, Boergesen M, Nielsen R, Mandrup S. Peroxisome proliferator-activated receptor gamma and C/EBPalpha synergistically activate key metabolic adipocyte genes by assisted loading. Mol Cell Biol. 2014;34:939-54. 

  102. Trends Endocrinol Metab M Armoni 18 100 2007 10.1016/j.tem.2007.02.001 Armoni M, Harel C, Karnieli E. Transcriptional regulation of the GLUT4 gene: from PPAR-gamma and FOXO1 to FFA and inflammation. Trends Endocrinol Metab. 2007;18:100-7. 

  103. Proc Natl Acad Sci USA V Puri 105 7833 2008 10.1073/pnas.0802063105 Puri V, Ranjit S, Konda S, Nicoloro SM, Straubhaar J, Chawla A, et al. Cidea is associated with lipid droplets and insulin sensitivity in humans. Proc Natl Acad Sci USA. 2008;105:7833-8. 

  104. Mol Cells JY Huh 37 365 2014 10.14348/molcells.2014.0074 Huh JY, Park YJ, Ham M, Kim JB. Crosstalk between adipocytes and immune cells in adipose tissue inflammation and metabolic dysregulation in obesity. Mol Cells. 2014;37:365-71. 

  105. Curr Diab Rep YH Lee 5 70 2005 10.1007/s11892-005-0071-7 Lee YH, Pratley RE. The evolving role of inflammation in obesity and the metabolic syndrome. Curr Diab Rep. 2005;5:70-5. 

  106. Int J Obes (Lond). S Park 40 460 2015 10.1038/ijo.2015.194 Park S, Park HL, Lee SY, Nam JH. Characteristics of adipose tissue macrophages and macrophage-derived insulin-like growth factor-1 in virus-induced obesity. Int J Obes (Lond). 2015;40:460-70. 

  107. Mediat Inflamm. A Rull 2010 326580 2010 10.1155/2010/326580 Rull A, Camps J, Alonso-Villaverde C, Joven J. Insulin resistance, inflammation, and obesity: role of monocyte chemoattractant protein-1 (or CCL2) in the regulation of metabolism. Mediat Inflamm. 2010;2010:326580. 

  108. Proc Natl Acad Sci USA P Sartipy 100 7265 2003 10.1073/pnas.1133870100 Sartipy P, Loskutoff DJ. Monocyte chemoattractant protein 1 in obesity and insulin resistance. Proc Natl Acad Sci USA. 2003;100:7265-70. 

  109. Int J Obes (Lond) HN Na 38 1470 2014 10.1038/ijo.2014.41 Na HN, Nam JH. Proof-of-concept for a virus-induced obesity vaccine; vaccination against the obesity agent adenovirus 36. Int J Obes (Lond). 2014;38:1470-4. 

  110. Microbiol Immunol. HN Na 58 303 2014 10.1111/1348-0421.12146 Na HN, Park S, Jeon HJ, Kim HB, Nam JH. Reduction of adenovirus 36-induced obesity and inflammation by mulberry extract. Microbiol Immunol. 2014;58:303-6. 

  111. Lancet Infect Dis NV Dhurandhar 11 963 2011 10.1016/S1473-3099(11)70274-2 Dhurandhar NV. A framework for identification of infections that contribute to human obesity. Lancet Infect Dis. 2011;11:963-9. 

  112. Front Immunol. MJ Kraakman 5 470 2014 10.3389/fimmu.2014.00470 Kraakman MJ, Murphy AJ, Jandeleit-Dahm K, Kammoun HL. Macrophage polarization in obesity and type 2 diabetes: weighing down our understanding of macrophage function? Front Immunol. 2014;5:470. 

  113. Front Immunol. A Castoldi 6 637 2015 Castoldi A, Naffah de Souza C, Camara NO, Moraes-Vieira PM. The macrophage switch in obesity development. Front Immunol. 2015;6:637. 

  114. Diabetes. S Fujisaka 58 2574 2009 10.2337/db08-1475 Fujisaka S, Usui I, Bukhari A, Ikutani M, Oya T, Kanatani Y, et al. Regulatory mechanisms for adipose tissue M1 and M2 macrophages in diet-induced obese mice. Diabetes. 2009;58:2574-82. 

  115. Chem Immunol Allergy Y Cao 99 170 2014 10.1159/000353254 Cao Y. Angiogenesis as a therapeutic target for obesity and metabolic diseases. Chem Immunol Allergy. 2014;99:170-9. 

  116. J Clin Invest K Sun 121 2094 2011 10.1172/JCI45887 Sun K, Kusminski CM, Scherer PE. Adipose tissue remodeling and obesity. J Clin Invest. 2011;121:2094-101. 

  117. Biochem Pharmacol. D Lin 119 8 2016 10.1016/j.bcp.2016.05.005 Lin D, Chun TH, Kang L. Adipose extracellular matrix remodelling in obesity and insulin resistance. Biochem Pharmacol. 2016;119:8-16. 

  118. Clin Sci (Lond) M Blüher 130 1603 2016 10.1042/CS20160005 Blüher M. Adipose tissue inflammation: a cause or consequence of obesity-related insulin resistance? Clin Sci (Lond). 2016;130:1603-14. 

  119. Diabetes. KA Gallagher 64 1420 2015 10.2337/db14-0872 Gallagher KA, Joshi A, Carson WF, Schaller M, Allen R, Mukerjee S, et al. Epigenetic changes in bone marrow progenitor cells influence the inflammatory phenotype and alter wound healing in type 2 diabetes. Diabetes. 2015;64:1420-30. 

  120. Blood. M Ishii 114 3244 2009 10.1182/blood-2009-04-217620 Ishii M, Wen H, Corsa CA, Liu T, Coelho AL, Allen RM, et al. Epigenetic regulation of the alternatively activated macrophage phenotype. Blood. 2009;114:3244-54. 

LOADING...

활용도 분석정보

상세보기
다운로드
내보내기

활용도 Top5 논문

해당 논문의 주제분야에서 활용도가 높은 상위 5개 콘텐츠를 보여줍니다.
더보기 버튼을 클릭하시면 더 많은 관련자료를 살펴볼 수 있습니다.

관련 콘텐츠

유발과제정보 저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로